Canadian study of travatan as replacement therapy (CSTART): Switching to Travatan can improve long-term care

Clinical and Surgical Ophthalmology

Volumn 21, Issue 10, 2003, Pages 426-429

  Klein, Thomas ^a  

^a Osler Eyecare   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ADRENALIN; BETAXOLOL; BETOPTIC S; BIMATOPROST; BRIMONIDINE; DORZOLAMIDE; DORZOLAMIDE PLUS TIMOLOL; LATANOPROST; PILOCARPINE; PROSTAGLANDIN DERIVATIVE; TIMOLOL MALEATE; TRAVOPROST;

CATARACT; CLINICAL TRIAL; CONFERENCE PAPER; CONJUNCTIVA DISEASE; DIARRHEA; DRUG CHOICE; DRUG HYPERSENSITIVITY; ELECTROLYTE DISTURBANCE; ERYTHEMA; EYE COLOR; EYE DISEASE; EYE IRRITATION; EYE PAIN; FATIGUE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GLAUCOMA; HAIR GROWTH; HEART DISEASE; HUMAN; HYPEREMIA; HYPERPIGMENTATION; IMPOTENCE; INCIDENCE; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; LONG TERM CARE; METABOLIC DISORDER; MONOTHERAPY; MYOPIA; NIGHT VISION; OPEN ANGLE GLAUCOMA; PATIENT COMPLIANCE; PIGMENT DISORDER; RESPIRATORY TRACT DISEASE; SIDE EFFECT; TASTE DISORDER; TREATMENT OUTCOME; VISUAL DISORDER; XEROSTOMIA;

EID: 9344246837     PISSN: 17054842     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (5)

1. The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of ocular pressure and visual field deterioration. Am J Ophthalmol 2000; 130:(4): 429-440.
2. Kass MA, Heuer DK et al. The Ocular Hypertension Treatment Study: A randomized trial determines that topical ocular hypotensive medication delays and prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002; 120(6): 701-713.
3. Licter P. Expectations from Clinical Trials - Results of the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002; 120: 1371-1372.
4. Collaborative Initial Glaucoma Treatment Study (CIGTS). Ophthalmology 2001; 108: 1943-1965.
5. Patel SC, Spaeth GL. Compliance in patients prescribed eye drops for glaucoma. Ophthalmic Surg 1995; 26: 2.